Cargando…

Corrigendum: SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines

Detalles Bibliográficos
Autores principales:	Singh, Desh Deepak, Parveen, Amna, Yadav, Dharmendra Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199444/ https://www.ncbi.nlm.nih.gov/pubmed/35719332 http://dx.doi.org/10.3389/fcimb.2022.885482

Ejemplares similares

SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2021)

SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases
por: Nayak, Baibaswata, et al.
Publicado: (2021)

Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach
por: Mohammad, Taj, et al.
Publicado: (2021)

Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Tang, Haijun, et al.
Publicado: (2021)

SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms
por: Li, Jiaqi, et al.
Publicado: (2022)

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
por: Yu, Kaikai, et al.
Publicado: (2023)

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
por: Bajpai, Prashant, et al.
Publicado: (2022)

Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
por: Singh, Desh Deepak, et al.
Publicado: (2021)

Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant
por: Wu, Jiajun, et al.
Publicado: (2022)

Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020)

A Saliva-Based RNA Extraction-Free Workflow Integrated With Cas13a for SARS-CoV-2 Detection
por: Azmi, Iqbal, et al.
Publicado: (2021)

How concerning is a SARS-CoV-2 variant of concern? Computational predictions and the variants labeling system
por: Ashoor, Dana, et al.
Publicado: (2022)

Enzyme linked oligonucleotide assay for the sensitive detection of SARS-CoV-2 variants
por: Shola David, Michael, et al.
Publicado: (2022)

Survival and detection of SARS-CoV-2 variants on dry swabs post storage
por: Gordhan, Bhavna G., et al.
Publicado: (2022)

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
por: Wen, Kun, et al.
Publicado: (2023)

Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach
por: Kushwaha, Prem Prakash, et al.
Publicado: (2021)

The Impact of Accumulated Mutations in SARS-CoV-2 Variants on the qPCR Detection Efficiency
por: Cao, Liu, et al.
Publicado: (2022)

Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays
por: Borillo, Gwynngelle A., et al.
Publicado: (2022)

Emerging Roles of Extracellular Vesicles in Pneumococcal Infections: Immunomodulators to Potential Novel Vaccine Candidates
por: Parveen, Saba, et al.
Publicado: (2022)

Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern
por: Vanhulle, Emiel, et al.
Publicado: (2022)

Evaluation of an identification method for the SARS-CoV-2 Delta variant based on the amplification-refractory mutation system
por: Zhang, Qin, et al.
Publicado: (2023)

Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity
por: Tang, Haijun, et al.
Publicado: (2021)

SARS-COV-2 Variants: Differences and Potential of Immune Evasion
por: Hirabara, Sandro M., et al.
Publicado: (2022)

Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naïve and Recovered Individuals Vaccinated With Inactivated Vaccine
por: Zhang, Yuwei, et al.
Publicado: (2022)

Development of an Adeno-Associated Virus-Vectored SARS-CoV-2 Vaccine and Its Immunogenicity in Mice
por: Qin, Xi, et al.
Publicado: (2022)

SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles
por: Mishra, Tarun, et al.
Publicado: (2021)

Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms
por: Thom, Ruth E., et al.
Publicado: (2021)

A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors
por: Singh, Desh Deepak, et al.
Publicado: (2023)

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients
por: Tomiyama, Takahiro, et al.
Publicado: (2023)

Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations
por: Meredith, Rhys T., et al.
Publicado: (2023)

Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants
por: Lebourgeois, Samuel, et al.
Publicado: (2021)

Tracing the trajectories of SARS-CoV-2 variants of concern between December 2020 and September 2021 in the Canary Islands (Spain)
por: Ciuffreda, Laura, et al.
Publicado: (2022)

Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2
por: Kim, Dongbum, et al.
Publicado: (2023)

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

Studying the effects of booster shots and antibody responses to the SARS-CoV-2 vaccination over time in health personnel
por: Wu, Jingjing, et al.
Publicado: (2023)

A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022
por: Yu, Kaikai, et al.
Publicado: (2023)

Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
por: Yadav, Dharmendra Kumar, et al.
Publicado: (2021)

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
por: Hu, Caiqin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8bj706lu91iaojig8a65ausfr7